Bambusa Therapeutics
Latest round
- Series A
Last raised
- Feb 2025
Total raised
- $62M
Investors
- 9
About Bambusa Therapeutics
a. Bambusa Therapeutics is a biotechnology company that focuses on developing bispecific antibodies for the treatment of immunological and inflammatory disorders. In September 2024, Bambusa Therapeutics Inc. As of September 2024, Shanshan Xu is the CEO of the company. The company is developing transformative inflammatory and immunological therapeutics by leveraging validated targets to achieve disease profiles for multiple indications.
Who invested in Bambusa Therapeutics
9 investors across 2 rounds
See all investors in Bambusa Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Bambusa Therapeutics
Who invested in Bambusa Therapeutics?
Bambusa Therapeutics has 9 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Bambusa Therapeutics raised?
Bambusa Therapeutics has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Bambusa Therapeutics last raise money?
Bambusa Therapeutics's most recent round on record is a Series A, in Feb 2025.
What does Bambusa Therapeutics do?
Bambusa Therapeutics is a biotechnology company.
Where is Bambusa Therapeutics headquartered?
Bambusa Therapeutics is headquartered in Boston, US.
Which VCs invest in companies like Bambusa Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Bambusa Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Bambusa Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.